As of 31 Dec 2025, 1 institutional investors reported holding $1 in principal (par value) of GILEAD SCIENCES INC - CORPORATE OBLIG.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $1 | $4 | 400.0% | 1 | |
| 2025 Q3 | $1 | $4 | 400.0% | 1 | |
| 2025 Q2 | $1 | $4 | 400.0% | 1 | |
| 2025 Q1 | $1 | $4 | 400.0% | 1 | |
| 2024 Q4 | $1 | $4 | 400.0% | 1 | |
| 2024 Q3 | $1 | $4 | 400.0% | 1 | |
| 2024 Q2 | $1 | $4 | 400.0% | 1 | |
| 2024 Q1 | $1 | $4 | 400.0% | 1 | |
| 2023 Q4 | $1 | $4 | 400.0% | 1 | |
| 2023 Q3 | $1 | $4 | 400.0% | 1 | |
| 2023 Q2 | $1 | $4 | 400.0% | 1 | |
| 2023 Q1 | $1 | $4 | 400.0% | 1 | |
| 2022 Q4 | $1 | $4 | +$4 | 400.0% | 1 |
| 2017 Q3 | $0 | $0 | -$3,159,000 | 400.0% | 0 |
| 2017 Q2 | $44,643 | $3,159,000 | +$139,117 | 7076.14% | 1 |
| 2017 Q1 | $42,677 | $2,897,000 | +$275,262 | 6788.2% | 1 |
| 2016 Q4 | $38,622 | $2,766,000 | +$600,224 | 7161.72% | 1 |
| 2016 Q3 | $30,241 | $2,393,000 | +$1,591,166 | 7913.1% | 1 |
| 2016 Q2 | $10,133 | $845,000 | -$932,499,209 | 8339.09% | 1 |
| 2016 Q1 | $227,868,660 | $936,219,209 | -$15,921,562 | 411.29% | 48 |
| 2015 Q4 | $229,553,955 | $1,029,905,822 | -$184,047,723 | 447.0% | 56 |
| 2015 Q3 | $270,642,307 | $1,165,173,756 | +$2,443,824 | 428.88% | 60 |
| 2015 Q2 | $268,048,827 | $1,389,812,767 | -$88,946,431 | 515.63% | 61 |
| 2015 Q1 | $297,181,680 | $1,282,282,249 | -$155,203,477 | 430.83% | 60 |
| 2014 Q4 | $333,558,437 | $1,382,673,216 | -$801,675,568 | 414.0% | 65 |
| 2014 Q3 | $518,150,870 | $2,420,774,376 | -$261,217,968 | 466.97% | 69 |
| 2014 Q2 | $573,539,390 | $2,091,133,659 | -$488,398,143 | 364.51% | 66 |
| 2014 Q1 | $713,528,096 | $2,219,381,633 | -$476,539,233 | 311.07% | 66 |